Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The serotonin system in autism spectrum disorder: From biomarker to animal models.

Muller CL, Anacker AM, Veenstra-VanderWeele J.

Neuroscience. 2016 May 3;321:24-41. doi: 10.1016/j.neuroscience.2015.11.010. Epub 2015 Nov 11. Review.

PMID:
26577932
2.

Platelet studies in autism spectrum disorder patients and first-degree relatives.

Bijl N, Thys C, Wittevrongel C, De la Marche W, Devriendt K, Peeters H, Van Geet C, Freson K.

Mol Autism. 2015 Oct 23;6:57. doi: 10.1186/s13229-015-0051-y. eCollection 2015.

3.

Inverse fluoxetine effects on inhibitory brain activation in non-comorbid boys with ADHD and with ASD.

Chantiluke K, Barrett N, Giampietro V, Santosh P, Brammer M, Simmons A, Murphy DG, Rubia K.

Psychopharmacology (Berl). 2015 Jun;232(12):2071-82. doi: 10.1007/s00213-014-3837-2. Epub 2014 Dec 24.

4.

5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.

Ciranna L, Catania MV.

Front Cell Neurosci. 2014 Aug 27;8:250. doi: 10.3389/fncel.2014.00250. eCollection 2014. Review.

5.

Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion.

Daly E, Ecker C, Hallahan B, Deeley Q, Craig M, Murphy C, Johnston P, Spain D, Gillan N, Gudbrandsen M, Brammer M, Giampietro V, Lamar M, Page L, Toal F, Schmitz N, Cleare A, Robertson D, Rubia K, Murphy DG.

Brain. 2014 Sep;137(Pt 9):2600-10. doi: 10.1093/brain/awu178. Epub 2014 Jul 28.

6.

Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome.

Uutela M, Lindholm J, Rantamäki T, Umemori J, Hunter K, Võikar V, Castrén ML.

Front Cell Neurosci. 2014 May 28;8:150. doi: 10.3389/fncel.2014.00150. eCollection 2014.

7.

γ-band abnormalities as markers of autism spectrum disorders.

Rojas DC, Wilson LB.

Biomark Med. 2014;8(3):353-68. doi: 10.2217/bmm.14.15. Review.

8.

Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome.

Wassink TH, Hazlett HC, Davis LK, Reiss AL, Piven J.

J Neurodev Disord. 2014 Mar 26;6(1):6. doi: 10.1186/1866-1955-6-6.

9.

Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism.

Chantiluke K, Barrett N, Giampietro V, Brammer M, Simmons A, Murphy DG, Rubia K.

Cereb Cortex. 2015 Jul;25(7):1757-70. doi: 10.1093/cercor/bht365. Epub 2014 Jan 22.

10.

Neuropathology and animal models of autism: genetic and environmental factors.

Gadad BS, Hewitson L, Young KA, German DC.

Autism Res Treat. 2013;2013:731935. doi: 10.1155/2013/731935. Epub 2013 Sep 16. Review.

11.

Parental broader autism subphenotypes in ASD affected families: relationship to gender, child's symptoms, SSRI treatment, and platelet serotonin.

Levin-Decanini T, Maltman N, Francis SM, Guter S, Anderson GM, Cook EH, Jacob S.

Autism Res. 2013 Dec;6(6):621-30. doi: 10.1002/aur.1322. Epub 2013 Aug 16.

12.

Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism.

Oblak A, Gibbs TT, Blatt GJ.

Autism Res. 2013 Dec;6(6):571-83. doi: 10.1002/aur.1317. Epub 2013 Jul 24.

13.

Links between genetics and pathophysiology in the autism spectrum disorders.

Holt R, Monaco AP.

EMBO Mol Med. 2011 Aug;3(8):438-50. doi: 10.1002/emmm.201100157. Review.

14.

MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders.

Tassone F, Qi L, Zhang W, Hansen RL, Pessah IN, Hertz-Picciotto I.

Autism Res. 2011 Aug;4(4):250-61. doi: 10.1002/aur.196. Epub 2011 Apr 29.

15.

Parent-of-origin effects of the serotonin transporter gene associated with autism.

Kistner-Griffin E, Brune CW, Davis LK, Sutcliffe JS, Cox NJ, Cook EH Jr.

Am J Med Genet B Neuropsychiatr Genet. 2011 Mar;156(2):139-44. doi: 10.1002/ajmg.b.31146. Epub 2010 Dec 8.

16.

DIA1R is an X-linked gene related to Deleted In Autism-1.

Aziz A, Harrop SP, Bishop NE.

PLoS One. 2011 Jan 17;6(1):e14534. doi: 10.1371/journal.pone.0014534.

17.

Family-based association study of ITGB3 in autism spectrum disorder and its endophenotypes.

Napolioni V, Lombardi F, Sacco R, Curatolo P, Manzi B, Alessandrelli R, Militerni R, Bravaccio C, Lenti C, Saccani M, Schneider C, Melmed R, Pascucci T, Puglisi-Allegra S, Reichelt KL, Rousseau F, Lewin P, Persico AM.

Eur J Hum Genet. 2011 Mar;19(3):353-9. doi: 10.1038/ejhg.2010.180. Epub 2010 Nov 24.

18.

Neurobehavioral abnormalities in first-degree relatives of individuals with autism.

Mosconi MW, Kay M, D'Cruz AM, Guter S, Kapur K, Macmillan C, Stanford LD, Sweeney JA.

Arch Gen Psychiatry. 2010 Aug;67(8):830-40. doi: 10.1001/archgenpsychiatry.2010.87. Erratum in: Arch Gen Psychiatry. 2011 Jan;68(1):60.

19.

Blood mercury concentrations in CHARGE Study children with and without autism.

Hertz-Picciotto I, Green PG, Delwiche L, Hansen R, Walker C, Pessah IN.

Environ Health Perspect. 2010 Jan;118(1):161-6. doi: 10.1289/ehp.0900736.

20.

Relationship between whole blood serotonin and repetitive behaviors in autism.

Kolevzon A, Newcorn JH, Kryzak L, Chaplin W, Watner D, Hollander E, Smith CJ, Cook EH Jr, Silverman JM.

Psychiatry Res. 2010 Feb 28;175(3):274-6. doi: 10.1016/j.psychres.2009.02.008. Epub 2009 Dec 30.

Items per page

Supplemental Content

Write to the Help Desk